Tactile Systems Technology Inc TCMD
Tactile Systems Technology Inc (Nasdaq: TCMD) is a medical device company. Its next catalyst on record is MyoSleeve: Commercial availability in VA/DoD channels (Q4 2026).
Upcoming catalysts
No catalyst is dated to the next 30 days or to an FDA action date.
Next further out: MyoSleeve — Commercial availability in VA/DoD channels (Q4 2026). 1 catalyst on record beyond the next 30 days; subscribers see each with its filing sentence.
Pipeline
| Program | Indication | Modality | Stage |
|---|---|---|---|
| Flexitouch Plus | Lymphedema (head/neck, phlebolymphedema, lipedema) | device-combination | NA_NON_THERAPEUTIC |
| Nimbl | Upper and lower extremity lymphedema | device-combination | NA_NON_THERAPEUTIC |
| Entre Plus | Lymphedema | device-combination | NA_NON_THERAPEUTIC |
| AffloVest Gen 6 | Bronchiectasis and neuromuscular disorders (airway clearance) | device-combination | NA_NON_THERAPEUTIC |
| MyoSleeve | Lower leg compression | device-combination | NA_NON_THERAPEUTIC |
Recent results and decisions
- Nov 2, 2026approval Tactile Medical received FDA 510(k) clearance expanding the LymphaTech 3D Scanner's indication to aid in the assessment of lymphedema.
Received FDA 510(k) clearance expanding the LymphaTech 3D Scanner's indication to aid in the assessment of lymphedema
Filing - Nov 2, 2026submitted Tactile Medical submitted a 510(k) application to FDA for Flexitouch Pro, featuring enhancements to the Company's advanced pneumatic compression system.
Submitted a 510(k) application to the FDA for Flexitouch® Pro, featuring enhancements to the Company's advanced pneumatic compression system
Filing
For subscribers
- Cash runway against each catalyst, with the company's own runway statement
- Track record: every Phase 3 readout, FDA decision and guidance slip since 2014
- Expected move for each dated catalyst, from comparable past events
- Phase 2 evidence behind each Phase 3 readout
- Companies on the same target or class
- Full catalyst list with filing sentences, deals, registered trials, Excel export
The free Monday brief
Last week's readouts and FDA decisions and the dated catalysts in the week ahead, each with its filing sentence.